137 related articles for article (PubMed ID: 34838790)
1. The Contribution of LIGHT (TNFSF14) to the Development of Systemic Sclerosis by Modulating IL-6 and T Helper Type 1 Chemokine Expression in Dermal Fibroblasts.
Ikawa T; Ichimura Y; Miyagawa T; Fukui Y; Toyama S; Omatsu J; Awaji K; Norimatsu Y; Watanabe Y; Yoshizaki A; Sato S; Asano Y
J Invest Dermatol; 2022 Jun; 142(6):1541-1551.e3. PubMed ID: 34838790
[TBL] [Abstract][Full Text] [Related]
2. Systemic Sclerosis Dermal Fibroblasts Suppress Th1 Cytokine Production via Galectin-9 Overproduction due to Fli1 Deficiency.
Saigusa R; Asano Y; Nakamura K; Hirabayashi M; Miura S; Yamashita T; Taniguchi T; Ichimura Y; Takahashi T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
J Invest Dermatol; 2017 Sep; 137(9):1850-1859. PubMed ID: 28528914
[TBL] [Abstract][Full Text] [Related]
3. Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis.
Taniguchi T; Asano Y; Nakamura K; Yamashita T; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sato S
J Rheumatol; 2017 Aug; 44(8):1198-1205. PubMed ID: 28507181
[TBL] [Abstract][Full Text] [Related]
4. An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis.
Castelino FV; Bain G; Pace VA; Black KE; George L; Probst CK; Goulet L; Lafyatis R; Tager AM
Arthritis Rheumatol; 2016 Dec; 68(12):2964-2974. PubMed ID: 27390295
[TBL] [Abstract][Full Text] [Related]
5. Low herpesvirus entry mediator (HVEM) expression on dermal fibroblasts contributes to a Th2-dominant microenvironment in advanced cutaneous T-cell lymphoma.
Miyagaki T; Sugaya M; Suga H; Morimura S; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
J Invest Dermatol; 2012 Apr; 132(4):1280-9. PubMed ID: 22297640
[TBL] [Abstract][Full Text] [Related]
6. Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells.
Saigusa R; Asano Y; Taniguchi T; Hirabayashi M; Nakamura K; Miura S; Yamashita T; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Trojanowska M; Sato S
Arthritis Res Ther; 2018 Feb; 20(1):23. PubMed ID: 29415756
[TBL] [Abstract][Full Text] [Related]
7. A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis.
Yamashita T; Asano Y; Taniguchi T; Nakamura K; Saigusa R; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
Exp Dermatol; 2016 Apr; 25(4):287-92. PubMed ID: 26661692
[TBL] [Abstract][Full Text] [Related]
8. Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.
Akamata K; Asano Y; Aozasa N; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sato S
Arthritis Res Ther; 2014 Apr; 16(2):R86. PubMed ID: 24708674
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis.
Akamata K; Asano Y; Taniguchi T; Yamashita T; Saigusa R; Nakamura K; Noda S; Aozasa N; Toyama T; Takahashi T; Ichimura Y; Sumida H; Tada Y; Sugaya M; Kadono T; Sato S
Rheumatology (Oxford); 2015 Jul; 54(7):1308-16. PubMed ID: 25539827
[TBL] [Abstract][Full Text] [Related]
10. Fli1 deficiency suppresses RALDH1 activity of dermal dendritic cells and related induction of regulatory T cells: a possible role in scleroderma.
Miura S; Watanabe Y; Saigusa R; Yamashita T; Nakamura K; Hirabayashi M; Miyagawa T; Yoshizaki A; Trojanowska M; Sato S; Asano Y
Arthritis Res Ther; 2021 May; 23(1):137. PubMed ID: 33964960
[TBL] [Abstract][Full Text] [Related]
11. Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice.
Taniguchi T; Asano Y; Akamata K; Noda S; Takahashi T; Ichimura Y; Toyama T; Trojanowska M; Sato S
Arthritis Rheumatol; 2015 Feb; 67(2):517-26. PubMed ID: 25385187
[TBL] [Abstract][Full Text] [Related]
12. TNFSF14 (LIGHT) Exhibits Inflammatory Activities in Lung Fibroblasts Complementary to IL-13 and TGF-β.
da Silva Antunes R; Mehta AK; Madge L; Tocker J; Croft M
Front Immunol; 2018; 9():576. PubMed ID: 29616048
[TBL] [Abstract][Full Text] [Related]
13. CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis.
Taniguchi T; Miyagawa T; Toyama S; Yamashita T; Nakamura K; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sato S; Asano Y
Exp Dermatol; 2018 Sep; 27(9):1030-1037. PubMed ID: 29947047
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosis.
Yamashita T; Asano Y; Saigusa R; Taniguchi T; Nakamura K; Miura S; Toyama T; Takahashi T; Ichimura Y; Hirabayashi M; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
J Dermatol Sci; 2019 Jan; 93(1):24-32. PubMed ID: 30270117
[TBL] [Abstract][Full Text] [Related]
15. Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts.
Brembilla NC; Montanari E; Truchetet ME; Raschi E; Meroni P; Chizzolini C
Arthritis Res Ther; 2013 Oct; 15(5):R151. PubMed ID: 24289089
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of the TNF superfamily member LIGHT/TNFSF14 and its receptors (HVEM and LTßR) in patients with systemic sclerosis.
Gindzienska-Sieskiewicz E; Distler O; Reszec J; Jordan S; Bielecki P; Sieskiewicz A; Sulik A; Lukasik M; Bielecki M; Kowal K; Kowal-Bielecka O
Rheumatology (Oxford); 2019 Mar; 58(3):502-510. PubMed ID: 30508197
[TBL] [Abstract][Full Text] [Related]
17. Fli1 Downregulation in Scleroderma Myeloid Cells Has Profibrotic and Proinflammatory Effects.
Bujor AM; El Adili F; Parvez A; Marden G; Trojanowska M
Front Immunol; 2020; 11():800. PubMed ID: 32508810
[TBL] [Abstract][Full Text] [Related]
18. Decreased interleukin-20 expression in scleroderma skin contributes to cutaneous fibrosis.
Kudo H; Jinnin M; Asano Y; Trojanowska M; Nakayama W; Inoue K; Honda N; Kajihara I; Makino K; Fukushima S; Ihn H
Arthritis Rheumatol; 2014 Jun; 66(6):1636-47. PubMed ID: 24470401
[TBL] [Abstract][Full Text] [Related]
19. Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development.
Lambrecht S; Smith V; De Wilde K; Coudenys J; Decuman S; Deforce D; De Keyser F; Elewaut D
Arthritis Rheumatol; 2014 Feb; 66(2):418-27. PubMed ID: 24504814
[TBL] [Abstract][Full Text] [Related]
20. Progranulin Overproduction Due to Fli-1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor in Systemic Sclerosis.
Ichimura Y; Asano Y; Akamata K; Noda S; Taniguchi T; Takahashi T; Toyama T; Tada Y; Sugaya M; Sato S; Kadono T
Arthritis Rheumatol; 2015 Dec; 67(12):3245-55. PubMed ID: 26245842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
